About AVT
Browse Articles
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 20 Issue 3 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 1911 results:


Baseline drug resistance mutations are detectable in HCV genes NS3 and NS5A but not NS5B in acute and chronic HIV-coinfected patients

Adele L McCormick, Luke Moynihan, Malcolm J Macartney, Ana Garcia-Diaz, Colette Smith, Margaret A Johnson, Alison J Rodger, Sanjay Bhagani, Tanzina Haque, Daniel P Webster

Antiviral Therapy 2015; 20:361-363

Case report

Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS

Alice Trentalange, Andrea Calcagno, Stefania Raviolo, Adolfo Prochet, Sabrina Audagnotto, Valeria Ghisetti, Giovanni Di Perri, Stefano Bonora

Antiviral Therapy 2015; 20:357-359

Case report

Successful treatment with sofosbuvir of fibrosing cholestatic hepatitis C after liver transplantation in an HIV–HCV-coinfected patient

Patrick Borentain, Philippe Colson, Catherine Dhiver, Emilie Gregoire, Jean Hardwigsen, Danielle Botta-Fridlund, Stéphane Garcia, René Gerolami

Antiviral Therapy 2015; 20:353-356

Case report

The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy

Margherita Macera, Nicolina Capoluongo, Michele Gambardella, Mario Starace, Carmine Minichini, Mariantonietta Pisaturo, Giuseppe Pasquale, Nicola Coppola

Antiviral Therapy 2015; 20:349-352

Short communication

Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study

Bisher Akil, Gary Blick, Debbie P Hagins, Moti N Ramgopal, Gary J Richmond, Rafik M Samuel, Naomi Givens, Cindy Vavro, Ivy H Song, Brian Wynne, Mounir Ait-Khaled, the VIKING-4 study team

Antiviral Therapy 2015; 20:343-348

Short communication

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes

Jessica Cusato, Sarah Allegra, Lucio Boglione, Amedeo De Nicolò, Lorena Baietto, Giuseppe Cariti, Giovanni Di Perri, Antonio D’Avolio

Antiviral Therapy 2015; 20:335-341

Original article

Liver fibrosis progression despite HCV cure with antiviral therapy in HIV–HCV-coinfected patients

Pablo Labarga, Jose V Fernandez-Montero, Carmen de Mendoza, Pablo Barreiro, Javier Pinilla, Vincent Soriano

Antiviral Therapy 2015; 20:329-334

Original article

Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive patients

Kirsten L White, Rima Kulkarni, Damian J McColl, Martin S Rhee, Javier Szwarcberg, Andrew K Cheng, Michael D Miller

Antiviral Therapy 2015; 20:317-327

Original article

Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection

Joseph J Eron, David A Cooper, Roy T Steigbigel, Bonaventura Clotet, Patrick Yeni, Kim M Strohmaier, Anthony J Rodgers, Richard J Barnard, Bach-Yen T Nguyen, Hedy Teppler, the BENCHMRK Study Teams

Antiviral Therapy 2015; 20:307-315

Original article

Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatment

Tanuja N Gengiah, Julia H Botha, Nonhlanhla Yende-Zuma, Kogieleum Naidoo, Salim S Abdool Karim

Antiviral Therapy 2015; 20:297-306

Copyright © Nucleus Global 2015. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.